Xenon Pharmaceuticals (XENE) Receivables (2013 - 2025)
Xenon Pharmaceuticals (XENE) reported Receivables of $8.6 million for Q1 2025, up 938.3% year-over-year from $833000.0 in Q1 2024, and up 194.38% quarter-over-quarter from $2.9 million in Q4 2024.
Xenon Pharmaceuticals (XENE) Receivables (2013 - 2025) Analysis & Trends
Xenon Pharmaceuticals (XENE) has 13 years of Receivables data on file, last reported at $8.6 million in Q1 2025.
- Receivables for Q1 2025 came in at $8.6 million, up 938.3% year-over-year; the trailing twelve-month figure through Mar 2025 was $8.6 million (up 938.3% YoY), and the FY2024 annual result was $2.9 million, up 236.16% from the prior year.
- Receivables advanced to $8.6 million in Q1 2025 per XENE's latest filing, from $2.9 million in the prior quarter.
- Over five years, Receivables peaked at $8.6 million in Q1 2025 and troughed at $805000.0 in Q3 2023.
- A 5-year average of $2.5 million and a median of $2.5 million in 2022 frame the typical range for Receivables.
- The sharpest annual moves came in 2023 and 2025: Receivables plunged 67.57% in 2023, then soared 938.3% in 2025.
- A 5-year view of Receivables shows it stood at $2.8 million in 2021, then sank by 64.34% to $986000.0 in 2022, then declined by 11.36% to $874000.0 in 2023, then soared by 236.16% to $2.9 million in 2024, then jumped by 194.38% to $8.6 million in 2025.
- Business Quant data shows XENE's Receivables at $8.6 million in Q1 2025, $2.9 million in Q4 2024, and $938000.0 in Q3 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 13.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 2.00 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Xenon Pharmaceuticals | 4.61 Bn | 4.61 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2025 | 8.65 Mn |
| Dec 31, 2024 | 2.94 Mn |
| Sep 30, 2024 | 938,000.00 |
| Jun 30, 2024 | 853,000.00 |
| Mar 31, 2024 | 833,000.00 |
| Dec 31, 2023 | 874,000.00 |
| Sep 30, 2023 | 805,000.00 |
| Jun 30, 2023 | 2.12 Mn |
| Mar 31, 2023 | 2.22 Mn |
| Dec 31, 2022 | 986,000.00 |
| Sep 30, 2022 | 2.48 Mn |
| Jun 30, 2022 | 2.52 Mn |
| Mar 31, 2022 | 2.92 Mn |
| Dec 31, 2021 | 2.77 Mn |
| Sep 30, 2021 | 3.24 Mn |
| Jun 30, 2021 | 2.92 Mn |
| Mar 31, 2021 | 5.06 Mn |
| Dec 31, 2020 | 1.82 Mn |
| Sep 30, 2020 | 1.61 Mn |
| Jun 30, 2020 | 1.79 Mn |